News & Updates

Show Multimedia Only

Apixaban recommended for thromboprophylaxis in ovarian cancer patients on chemo

09 Sep 2025 by

Data presented at ESMO Gyn 2025 support apixaban as a prophylactic agent for venous thromboembolism (VTE) in women with epithelial ovarian cancer who are undergoing neoadjuvant chemotherapy consisting of carboplatin and paclitaxel.

Apixaban recommended for thromboprophylaxis in ovarian cancer patients on chemo

09 Sep 2025

Poor periconceptional glycaemic control magnifies pre-eclampsia risk in T1D

09 Sep 2025

Women with type 1 diabetes (T1D) have an increased risk of developing pre-eclampsia during pregnancy, and this risk gets is commensurate with worsening blood sugar control around the time of conception, according to a study from Sweden.

Poor periconceptional glycaemic control magnifies pre-eclampsia risk in T1D

09 Sep 2025

Real-world data support HPV vaccine efficacy in off-label age groups

09 Sep 2025 by

A prospective analysis demonstrates the effectiveness of HPV vaccination in reducing progression to biopsy-confirmed precancerous lesions and HPV persistence in a cohort of South Korean women in off-label age groups.

Real-world data support HPV vaccine efficacy in off-label age groups

09 Sep 2025

Outcomes in ICH patients not different with minimally invasive surgery vs medical management

08 Sep 2025

For patients with supratentorial intracerebral haemorrhage (ICH), minimally invasive surgery is not superior to medical management alone in terms of improving mortality and disability outcomes, according to data from the open-label MIND clinical trial.

Outcomes in ICH patients not different with minimally invasive surgery vs medical management

08 Sep 2025

Antihistamine nasal spray a promising prophylactic treatment against SARS-CoV-2

08 Sep 2025 by

The use of the antihistamine nasal spray azelastine may help prevent SARS-CoV-2 respiratory infections, as shown in a phase II study.

Antihistamine nasal spray a promising prophylactic treatment against SARS-CoV-2

08 Sep 2025

Propafenone reduces risks of proarrhythmia, death in AF patients with HF

08 Sep 2025

The use of propafenone shows no significant relationship with an elevated risk of proarrhythmia and mortality compared with amiodarone in atrial fibrillation (AF) patients with heart failure (HF), suggests a recent study.

Propafenone reduces risks of proarrhythmia, death in AF patients with HF

08 Sep 2025

Second cancers may develop in women with early invasive breast cancer

08 Sep 2025 by

Women treated for early invasive breast cancer have a slightly higher risk of a second primary cancer than those in the general population, reveals a study. Such risk is greater among younger women.

Second cancers may develop in women with early invasive breast cancer

08 Sep 2025

Alirocumab lowers LDL-C levels in patients with ACS

08 Sep 2025

Long-term treatment with alirocumab with or without lipid-lowering therapy treatment significantly reduced the levels of low-density lipoprotein cholesterol (LDL-C) in patients with acute coronary syndrome (ACS), as shown by the results of a real-world evidence study.

Alirocumab lowers LDL-C levels in patients with ACS

08 Sep 2025

Sleep duration mediates link between screen time in late childhood and depression

08 Sep 2025

Children who spend more screen time are at increased risk of having more depressive symptoms, potentially due to shorter sleep and worse white matter organization during early adolescence, according to a study.

Sleep duration mediates link between screen time in late childhood and depression

08 Sep 2025

Raludotatug deruxtecan shows efficacy signal in platinum-sensitive ovarian cancer

07 Sep 2025 by

The cadherin 6 (CDH6)-directed antibody–drug conjugate raludotatug deruxtecan elicits response in heavily pretreated patients with platinum-sensitive ovarian cancer while having a manageable safety profile, according to a subgroup analysis of an ongoing first-in-human phase I trial.

Raludotatug deruxtecan shows efficacy signal in platinum-sensitive ovarian cancer

07 Sep 2025

News & Updates

Showing Multidisciplinary articles

Showing

Specialty:

Apixaban recommended for thromboprophylaxis in ovarian cancer patients on chemo

Apixaban recommended for thromboprophylaxis in ovarian cancer patients on chemo

Poor periconceptional glycaemic control magnifies pre-eclampsia risk in T1D

Poor periconceptional glycaemic control magnifies pre-eclampsia risk in T1D

Real-world data support HPV vaccine efficacy in off-label age groups

Real-world data support HPV vaccine efficacy in off-label age groups

Outcomes in ICH patients not different with minimally invasive surgery vs medical management

Outcomes in ICH patients not different with minimally invasive surgery vs medical management

Antihistamine nasal spray a promising prophylactic treatment against SARS-CoV-2

Antihistamine nasal spray a promising prophylactic treatment against SARS-CoV-2

Propafenone reduces risks of proarrhythmia, death in AF patients with HF

Propafenone reduces risks of proarrhythmia, death in AF patients with HF

Second cancers may develop in women with early invasive breast cancer

Second cancers may develop in women with early invasive breast cancer

Alirocumab lowers LDL-C levels in patients with ACS

Alirocumab lowers LDL-C levels in patients with ACS

Sleep duration mediates link between screen time in late childhood and depression

Sleep duration mediates link between screen time in late childhood and depression

Raludotatug deruxtecan shows efficacy signal in platinum-sensitive ovarian cancer

Raludotatug deruxtecan shows efficacy signal in platinum-sensitive ovarian cancer